<p>Pancreatic cancer cell lines were treated with GDC0941 alone, AZD6244 alone or GDC0941-AZD6244 in combination for 72 hours. Cell apoptosis was detected by flow cytometry. A, B: combinations vs. untreated groups (*p values <0.05), combinations vs. single agents (*p values <0.05), single agents vs. untreated groups (*p values <0.05). C, D: combinations vs. untreated groups (*p value <0.05) and combinations vs. single agents (*p value <0.05).</p
<p>Apoptosis of GFP and CXCL12-expressing MiaPaCa2 cells were assessed using the caspase 3/7 glo ass...
<p><b>A</b>) Cells treated with 5-AzadC and 4-PBA alone or in combination along with sham and untrea...
<p>A) Colony assay. The indicated cell lines were treated with ½ of the IC<sub>50</sub> dose of AZD2...
<p>Cells were treated with varying concentrations of GDC0941 (A) or AZD6244 (B) alone for 72 hours. ...
<p>BxPC-3 (A) and MIA PaCa-2 cells (B) were treated with GDC0941 alone, AZD6244 alone or GDC0941-AZD...
<p>All four pancreatic cancer cell lines were treated with the GDC0941-AZD6244 combination for 24 ho...
Pancreatic cancer cell lines BxPC-3 (A), Capan-2 (B), MIA PaCa-2 (C), PANC-1 (D), and Hs766T (E) wer...
<p>(A) A549 and H157 were treated with AZD6244, MK2206, or a combination of these two compounds at t...
<p><b>A.</b> MTT results showed the 2ME and CsA effect on cell proliferation. After treated by 2ME a...
Temozolomide (TMZ) is used in the standard therapy regimen for patients with glioblastoma (GBM). How...
Pancreatic cancer is a leading cause of cancer related deaths worldwide and has a low survival rate ...
Abstract Background P276-00 is a novel cyclin-dependent kinase inhibitor currently in Phase II clini...
Pancreatic cancer is a leading cause of cancer related deaths worldwide and has a low survival rate ...
Pancreatic cancer is a leading cause of cancer related deaths worldwide and has a low survival rate ...
<p>Both MIA PaCa-2 and PANC-1 cells were treated with 400 nm GDC0941, 200 nM AZD6244 or a combinatio...
<p>Apoptosis of GFP and CXCL12-expressing MiaPaCa2 cells were assessed using the caspase 3/7 glo ass...
<p><b>A</b>) Cells treated with 5-AzadC and 4-PBA alone or in combination along with sham and untrea...
<p>A) Colony assay. The indicated cell lines were treated with ½ of the IC<sub>50</sub> dose of AZD2...
<p>Cells were treated with varying concentrations of GDC0941 (A) or AZD6244 (B) alone for 72 hours. ...
<p>BxPC-3 (A) and MIA PaCa-2 cells (B) were treated with GDC0941 alone, AZD6244 alone or GDC0941-AZD...
<p>All four pancreatic cancer cell lines were treated with the GDC0941-AZD6244 combination for 24 ho...
Pancreatic cancer cell lines BxPC-3 (A), Capan-2 (B), MIA PaCa-2 (C), PANC-1 (D), and Hs766T (E) wer...
<p>(A) A549 and H157 were treated with AZD6244, MK2206, or a combination of these two compounds at t...
<p><b>A.</b> MTT results showed the 2ME and CsA effect on cell proliferation. After treated by 2ME a...
Temozolomide (TMZ) is used in the standard therapy regimen for patients with glioblastoma (GBM). How...
Pancreatic cancer is a leading cause of cancer related deaths worldwide and has a low survival rate ...
Abstract Background P276-00 is a novel cyclin-dependent kinase inhibitor currently in Phase II clini...
Pancreatic cancer is a leading cause of cancer related deaths worldwide and has a low survival rate ...
Pancreatic cancer is a leading cause of cancer related deaths worldwide and has a low survival rate ...
<p>Both MIA PaCa-2 and PANC-1 cells were treated with 400 nm GDC0941, 200 nM AZD6244 or a combinatio...
<p>Apoptosis of GFP and CXCL12-expressing MiaPaCa2 cells were assessed using the caspase 3/7 glo ass...
<p><b>A</b>) Cells treated with 5-AzadC and 4-PBA alone or in combination along with sham and untrea...
<p>A) Colony assay. The indicated cell lines were treated with ½ of the IC<sub>50</sub> dose of AZD2...